Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statement of Changes in Stockholders Equity (Deficiency)

v3.5.0.2
Interim Consolidated Statement of Changes in Stockholders Equity (Deficiency) - USD ($)
Common Shares [Member]
Additional Paid-In Capital [Member]
Deficiency [Member]
Accumulated Other Comprehensive loss [Member]
Total
Beginning Balance at Nov. 30, 2014 $ 46,899 $ 24,024,631 $ (24,042,769) $ (31,706) $ (2,945)
Beginning Balance (Shares) at Nov. 30, 2014 46,899,285        
Issue of common shares $ 7,576 2,492,424     2,500,000
Issue of common shares (Shares) 7,575,757        
Exercise of options $ 35 6,960     6,995
Exercise of options (Shares) 35,000        
Exercise of warrants $ 106 16,669     16,775
Exercise of warrants (Shares) 105,600        
Stock based compensation for issue of options   422,459     422,459
Stock based compensation for modification of warrants   216,684     216,684
Net loss for the period     (2,550,438)   (2,550,438)
Foreign currency translation       (15,033) (15,033)
Ending Balance at Nov. 30, 2015 $ 54,616 27,179,827 (26,593,207) (46,739) 594,497
Ending Balance (Shares) at Nov. 30, 2015 54,615,642        
Stock based compensation for issue of options   2,574     2,574
Net loss for the period     (1,343,954)   (1,343,954)
Foreign currency translation       (9,132) (9,132)
Ending Balance at Aug. 31, 2016 $ 54,616 $ 27,182,401 $ (27,937,161) $ (55,871) $ (756,015)
Ending Balance (Shares) at Aug. 31, 2016 54,615,642